losoxantrone has been researched along with teloxantrone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, P; Novak, RF | 1 |
| Kohlhagen, G; Leteurtre, F; Paull, KD; Pommier, Y | 1 |
| Gogas, H; Mansi, JL | 1 |
1 review(s) available for losoxantrone and teloxantrone
| Article | Year |
|---|---|
New drugs. The anthrapyrazoles.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Humans; Pyrazoles; Pyrazolones | 1996 |
2 other study(ies) available for losoxantrone and teloxantrone
| Article | Year |
|---|---|
Effects of anthrapyrazole antineoplastic agents on lipid peroxidation.
Topics: Amsacrine; Animals; Anthraquinones; Antineoplastic Agents; Doxorubicin; In Vitro Techniques; Iron; Lipid Peroxides; Male; Microsomes, Liver; Pyrazoles; Pyrazolones; Rabbits | 1986 |
Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen.
Topics: Anthraquinones; Antineoplastic Agents; Base Sequence; Drug Screening Assays, Antitumor; Humans; Molecular Sequence Data; National Institutes of Health (U.S.); Pyrazoles; Pyrazolones; Topoisomerase II Inhibitors; Tumor Cells, Cultured; United States | 1994 |